Stockreport

Raymond James Increases PT on Dyne Therapeutics Stock from $31 to $35, Maintains Buy Rating [Yahoo! Finance]

Dyne Therapeutics, Inc.  (DYN) 
Last dyne therapeutics, inc. earnings: 11/1 04:30 pm Check Earnings Report
US:NYSE Investor Relations: dynegy.com/investors/presentations-events
PDF 25, Raymond James increased the price target on Dyne Therapeutics, Inc. (NASDAQ:DYN) stock from $31 to $35, maintaining its Buy rating. Martin Auster from Raymond Jame [Read more]